Day: 10 September 2025

Efficacy and Tolerability of Integrase Inhibitors in Antiretroviral-Naive Patients

HIV prevalence and its association with cervical cancer risk in southern Africa: a systematic review and meta-analysis

Introduction HIV infection and cervical cancer are major public health challenges worldwide, particularly in regions where HIV is endemic1,2. Cervical cancer, one of the most common cancers among women, causes significant loss of life, especially in developing countries where access to preventive care and screening remains limited3. According to the World Health Organization4, approximately 660,000 […]

Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice

HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: Unraveling the Complexity of an Outlier 25 Years Later

Antiretroviral Therapy in Primary HIV-1 Infection: Influences on Immune Activation and Gut Mucosal Barrier Dysfunction

State of the Art of Dual Therapy in 2015

The START Trial: Definitive Evidence to Treat All HIV-Positive Persons Regardless of CD4 Counts

Antiviral Therapy must be Offered to all Hepatitis C Patients, as Antiretrovirals to all HIV-Positive Individuals

Hepatitis B Reactivation During Successful HCV Therapy

HIV Protease Inhibitors Associated with Increased HCV Viral Load in Coinfected Patients